Semaglutide riduce il grasso nel fegato in 9 adulti su 10 con obesità e steatosi epatica #EASD2026
Presentati oggi a Milano, in occasione del 62° Congresso annuale della European Association for the Study of Diabetes (EASD), i dati di un’analisi post hoc dello studio STEP UP di…
Long naps may increase the risk of chronic liver disease in people with diabetes
People with type 2 diabetes who nap longer than 30 minutes every day, regardless of their sleep patterns at night, increase their risk of developing metabolic dysfunction-associated steatotic liver disease…
IL 19% DEI BAMBINI È IN SOVRAPPESO E IL 9,8% OBESO IN ITALIA. ATTENZIONE A ENERGY DRINK E CIBI ULTRAFORMULATI
L’obesità infantile non è solo una questione di peso, ma una condizione complessa che coinvolge metabolismo, sistema cardiovascolare, fegato ed equilibrio psicofisico e rappresenta un problema di salute pubblica in…
Low testosterone, high fructose: A recipe for liver disaster
Low testosterone in itself can cause a variety of health problems, but the addition of a poor diet can exacerbate certain conditions. Metabolic dysfunction-associated steatotic liver disease (MASLD) is one…
Menopause at an earlier age increases risk of fatty liver disease and metabolic disorders
Women who experience menopause before the age of 50 — and especially before the age of 45 — are more likely to develop fatty liver disease and its related metabolic…
AI finds undiagnosed liver disease in early stages #TLM2024 #AASLD24
Liver disease, which is treatable when discovered early, often goes undetected until late stages, but a new study revealed that an algorithm fueled by artificial intelligence can accurately detect early-stage…
Semaglutide Reduces Severity of Common Liver Disease in People with HIV #CROI2024
A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31% in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD), according…